Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Seibold

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|December 1, 1991
Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitisR Klein, J Eisenburg, P Weber, et al.
Gut|May 1, 1992
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitisF Seibold, P Weber, R Klein, et al.
European Journal of Gastroenterology & Hepatology|November 1, 1996
Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?F Seibold, P Weber, A Schöning, et al.
Journal of Crohn'S & Colitis|April 10, 2013
Topical therapy is underused in patients with ulcerative colitisF Seibold, N Fournier, C Beglinger, et al.
Neurogastroenterology and Motility|August 13, 2008
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patientsA M Schoepfer, T Schaffer, B Seibold-Schmid, et al.
Gut|April 1, 1997
Pancreatic autoantibodies in Crohn's disease: a family studyF Seibold, H Mörk, S Tanza, et al.
Scandinavian Journal of Gastroenterology|April 8, 2003
Amelioration of murine colitis by feeding a solution of lysed Escherichia coliA Konrad, M Mähler, B Flogerzi, et al.
Gastroenterology|May 30, 1998
Regional differences in L-selectin expression in murine intestinal lymphocytesF Seibold, B Seibold-Schmid, Y Cong, et al.
Alimentary Pharmacology & Therapeutics|July 8, 2015
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patientsE Safroneeva, S Vavricka, N Fournier, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|December 1, 1991
Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitisR Klein, J Eisenburg, P Weber, et al.
Gut|May 1, 1992
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitisF Seibold, P Weber, R Klein, et al.
European Journal of Gastroenterology & Hepatology|November 1, 1996
Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?F Seibold, P Weber, A Schöning, et al.
Journal of Crohn'S & Colitis|April 10, 2013
Topical therapy is underused in patients with ulcerative colitisF Seibold, N Fournier, C Beglinger, et al.
Neurogastroenterology and Motility|August 13, 2008
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patientsA M Schoepfer, T Schaffer, B Seibold-Schmid, et al.
Gut|April 1, 1997
Pancreatic autoantibodies in Crohn's disease: a family studyF Seibold, H Mörk, S Tanza, et al.
Scandinavian Journal of Gastroenterology|April 8, 2003
Amelioration of murine colitis by feeding a solution of lysed Escherichia coliA Konrad, M Mähler, B Flogerzi, et al.
Gastroenterology|May 30, 1998
Regional differences in L-selectin expression in murine intestinal lymphocytesF Seibold, B Seibold-Schmid, Y Cong, et al.
Alimentary Pharmacology & Therapeutics|July 8, 2015
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patientsE Safroneeva, S Vavricka, N Fournier, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Pageof 4